Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 21, 2005; 11(35): 5433-5437
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5433
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5433
MGC803 | SGC7901 | |||||||
Control | Treated with allitridi | Control | Treated with allitridi | |||||
3 μg/mL | 6 μg/mL | 9 μg/mL | 3 μg/mL | 6 μg/mL | 9 μg/mL | |||
G0/G1 (%) | 57.2±3.1 | 27.5±2.8b | 12.4±1.7b | 3.3±0.6b | 62.1±2.4 | 27.7±1.0b | 17.9±3.8b | 13.2±1.7b |
S (%) | 14.4±1.6 | 13.6±1.4 | 12.4±2.2 | 11.2±1.3 | 10.1±0.5 | 12.3±0.1 | 13.7±2.1 | 12.1±0.4 |
G2/M (%) | 13.3±0.2 | 20.1±3.5b | 36.5±1.4b | 36.4±4.5b | 13.2±1.2 | 21.7±2.3b | 39.4±4.3b | 37.4±3.3b |
- Citation: Ha MW, Ma R, Shun LP, Gong YH, Yuan Y. Effects of allitridi on cell cycle arrest of human gastric cancer cells. World J Gastroenterol 2005; 11(35): 5433-5437
- URL: https://www.wjgnet.com/1007-9327/full/v11/i35/5433.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i35.5433